The Omni platform, available on both desktop and mobile devices, offers users the ability to track developments related to Key Opinion Leaders, including conferences, social media, and clinical trials in real time.
“We were emboldened by the feedback we received from our customers to develop a dynamic platform that can be widely adopted by Med Comm and Med Affairs teams as well as CI pros who have been relying on our solutions in the pharma industry for more than a decade,” said CEO Dr. Aviva Fridman. “I am excited to get Omni into the hands of customers who will benefit from instant access to their market and KOL data.”
Omni enables users to choose their target KOLs and access their activity instantly via their desktop or mobile device. Features include:
- Advanced KOL tracking: publications, upcoming events, clinical trials, Sunshine data, and social media relevant to specific KOLs
- Ability to easily identify critical news, bookmark, and add notes for the KOLs you follow
- A social experience: like, share, and comment on news items within organizations
- Additional releases are planned throughout 2019 to enhance Omni functionality including analytics, individual news feeds for pharmaceutical products, diseases, drug pipelines, mechanisms of action, and conference planners
About Larvol:
Larvol (www.larvol.com) provides SaaS solutions that support competitive intelligence, business intelligence, and medical communications departments in the pharmaceutical and biotech industry. Their products include secondary competitive intelligence reports, KOL tracking, and conference planning solutions. Larvol curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation to keep their customers at the forefront of the industry. The Larvol team consists of MDs and PhDs who curate data from over 25,000 sources and distill the most relevant findings into concise reports that provide real-time insights and time-saving analysis.
For more information about Larvol or sales inquiries, please contact us at info@larvol.com. New users can register at www.larvolomni.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190311005067/en/
Source: Larvol
View this news release online at:
http://www.businesswire.com/news/home/20190311005067/en
